Categories: News

HST Pathways and Advantien Form Strategic Partnership

This partnership enables orthopedic ASCs to access a centralized purchasing system, creating further efficiencies in operations and patient care

NASHVILLE, Tenn.–(BUSINESS WIRE)–HST Pathways, the leading provider of end-to-end software solutions for the ambulatory surgery center industry (ASC), and Advantien, the leading provider of innovative ASC supply chain solutions, have partnered to help ASCs further streamline their implant purchasing systems.

HST Pathways is a leader in ASC cloud-based technology with more than 15 years of experience in the industry. Offering a suite of solutions created specifically for surgery centers, HST Pathways provides a peerless experience for its customers including solutions to support surgery center management, electronic charting, scheduling and case coordination, digital patient engagement, patient estimation and authorization, and revenue cycle services.

Advantien provides ASCs with a customizable suite of implant supply chain services that streamline implant purchasing and billing, drive savings, and maximize facility profits — all without impacting surgeon choice in implants. Advantien’s Analytics Platform provides valuable insights on key implant performance metrics, allowing ASCs to make important data-driven decisions.

As part of this partnership, HST and Advantien will be providing a free implant spending report to any interested HST customer. By leveraging both HST Pathways and Advantien, the centralized purchasing solution simplifies daily tasks associated with implant purchasing, freeing ASC staff to focus on efficient operations and improving patient outcomes.

“We are excited about the opportunity to partner with the team at HST Pathways and provide their ASC customer base with access to Advantien’s innovative implant management solutions,” said Tim Burney, CEO of Advantien. “Implant management operations are an extremely high cost to ASCs, and this partnership provides the opportunity to offer very meaningful and significant savings to the ASC industry.”

“Visibility and optimization of implant costs is regularly highlighted as a top need for our ASC clients. We’re excited to partner with Advantien, a leader in ASC supply chain optimization and look forward to bringing their solutions and valuable benefits to our ASC customers, their facilities, and their patients,” said David Thawley, CEO of HST Pathways. “Advantien’s expertise in implant analytics aligns well with HST’s mission to help ASCs leverage technology and innovation to optimize their business, while delivering high-quality patient outcomes.”

With this strategic partnership, HST Pathways and Advantien will deliver enhanced innovation to the growing ASC industry.

About HST Pathways

HST Pathways, a Bain Capital Company, is the leading provider of a suite of products under the “HST One” membership offering, including practice management software, care coordination, revenue cycle optimization, supply chain management, case costing, patient engagement and communication, an electronic health record system, and data analytics. See why more than 1,400 clients are choosing HST Pathways by visiting www.hstpathways.com.

About Advantien

Advantien partners with ASCs to reduce ortho/spine implant costs, accelerate reimbursement and drive significant profits. Advantien’s industry-leading implant analytics empower value-based decision-making, and streamlined supply chain services simplify purchasing and billing. Learn how Advantien maximizes implant value at https://www.advantien.com/.

Contacts

HST Pathways:

Erica Palmer

Senior Content Marketing Manager

e. Erica.Palmer@hstpathways.com 

p. 203.464.5395

Advantien:

Jordan Webb

Executive VP, CCO

e. jwebb@advantien.com
p. 505.710.3855

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

10 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

13 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

13 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

13 hours ago